vs
GE医疗(CCRN)与RCM TECHNOLOGIES, INC.(RCMT)财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是RCM TECHNOLOGIES, INC.的2.7倍($236.8M vs $86.5M),RCM TECHNOLOGIES, INC.净利率更高(7.1% vs -35.0%,领先42.1%),RCM TECHNOLOGIES, INC.同比增速更快(12.4% vs -23.6%),过去两年RCM TECHNOLOGIES, INC.的营收复合增速更高(9.6% vs -21.0%)
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业,品牌标识为GE HealthCare。公司主要业务分为四大板块:包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务,以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务,此外还开展医药相关业务。
埃克塞拉科技是一家美国业务流程自动化企业,由SourceHOV、Novitex Holdings与Quinpario Acquisition Corp. 2合并组建,专注为各行业客户提供自动化业务解决方案,助力企业优化运营流程、提升运转效率。
CCRN vs RCMT — 直观对比
营收规模更大
CCRN
是对方的2.7倍
$86.5M
营收增速更快
RCMT
高出36.0%
-23.6%
净利率更高
RCMT
高出42.1%
-35.0%
两年增速更快
RCMT
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $236.8M | $86.5M |
| 净利润 | $-82.9M | $6.1M |
| 毛利率 | — | 28.1% |
| 营业利润率 | -30.2% | 9.2% |
| 净利率 | -35.0% | 7.1% |
| 营收同比 | -23.6% | 12.4% |
| 净利润同比 | -2109.7% | 112.9% |
| 每股收益(稀释后) | $-2.56 | $0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CCRN
RCMT
| Q1 26 | — | $86.5M | ||
| Q4 25 | $236.8M | — | ||
| Q3 25 | $250.1M | $70.3M | ||
| Q2 25 | $274.1M | $78.2M | ||
| Q1 25 | $293.4M | $84.5M | ||
| Q4 24 | $309.9M | $76.9M | ||
| Q3 24 | $315.1M | $60.4M | ||
| Q2 24 | $339.8M | $69.2M |
净利润
CCRN
RCMT
| Q1 26 | — | $6.1M | ||
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $2.3M | ||
| Q2 25 | $-6.7M | $3.8M | ||
| Q1 25 | $-490.0K | $4.2M | ||
| Q4 24 | $-3.8M | $2.9M | ||
| Q3 24 | $2.6M | $2.7M | ||
| Q2 24 | $-16.1M | $3.8M |
毛利率
CCRN
RCMT
| Q1 26 | — | 28.1% | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | 27.6% | ||
| Q2 25 | 20.4% | 28.5% | ||
| Q1 25 | 20.0% | 26.0% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | 20.4% | 29.6% | ||
| Q2 24 | 20.8% | 28.9% |
营业利润率
CCRN
RCMT
| Q1 26 | — | 9.2% | ||
| Q4 25 | -30.2% | — | ||
| Q3 25 | -2.4% | 5.6% | ||
| Q2 25 | -2.1% | 8.4% | ||
| Q1 25 | -0.3% | 7.8% | ||
| Q4 24 | -1.1% | 8.2% | ||
| Q3 24 | 0.9% | 7.3% | ||
| Q2 24 | -5.7% | 8.4% |
净利率
CCRN
RCMT
| Q1 26 | — | 7.1% | ||
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | 3.2% | ||
| Q2 25 | -2.4% | 4.8% | ||
| Q1 25 | -0.2% | 5.0% | ||
| Q4 24 | -1.2% | 3.7% | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | -4.7% | 5.4% |
每股收益(稀释后)
CCRN
RCMT
| Q1 26 | — | $0.80 | ||
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | $0.30 | ||
| Q2 25 | $-0.20 | $0.50 | ||
| Q1 25 | $-0.02 | $0.54 | ||
| Q4 24 | $-0.13 | $0.38 | ||
| Q3 24 | $0.08 | $0.35 | ||
| Q2 24 | $-0.47 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $2.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $46.0M |
| 总资产 | $449.0M | $134.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CCRN
RCMT
| Q1 26 | — | $2.9M | ||
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | $1.3M | ||
| Q2 25 | $81.2M | $5.5M | ||
| Q1 25 | $80.7M | $5.2M | ||
| Q4 24 | $81.6M | $4.7M | ||
| Q3 24 | $64.0M | $3.2M | ||
| Q2 24 | $69.6M | $3.5M |
股东权益
CCRN
RCMT
| Q1 26 | — | $46.0M | ||
| Q4 25 | $322.8M | — | ||
| Q3 25 | $408.1M | $41.4M | ||
| Q2 25 | $412.2M | $37.8M | ||
| Q1 25 | $418.2M | $34.6M | ||
| Q4 24 | $419.0M | $33.5M | ||
| Q3 24 | $424.7M | $30.0M | ||
| Q2 24 | $433.3M | $28.5M |
总资产
CCRN
RCMT
| Q1 26 | — | $134.4M | ||
| Q4 25 | $449.0M | — | ||
| Q3 25 | $538.2M | $129.8M | ||
| Q2 25 | $553.8M | $135.6M | ||
| Q1 25 | $576.2M | $121.0M | ||
| Q4 24 | $589.3M | $132.1M | ||
| Q3 24 | $597.4M | $125.5M | ||
| Q2 24 | $602.9M | $118.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $18.2M | $19.0M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | — |
| 自由现金流率自由现金流/营收 | 6.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | 3.11× |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势,按日历期对齐
经营现金流
CCRN
RCMT
| Q1 26 | — | $19.0M | ||
| Q4 25 | $18.2M | — | ||
| Q3 25 | $20.1M | $-1.3M | ||
| Q2 25 | $4.2M | $-7.9M | ||
| Q1 25 | $5.7M | $16.7M | ||
| Q4 24 | $24.2M | $-1.6M | ||
| Q3 24 | $7.5M | $-4.3M | ||
| Q2 24 | $82.4M | $5.7M |
自由现金流
CCRN
RCMT
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | $-1.8M | ||
| Q2 25 | $2.3M | $-8.4M | ||
| Q1 25 | $3.8M | $16.2M | ||
| Q4 24 | $21.7M | $-2.6M | ||
| Q3 24 | $6.3M | $-4.9M | ||
| Q2 24 | $79.6M | $5.3M |
自由现金流率
CCRN
RCMT
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | -2.5% | ||
| Q2 25 | 0.8% | -10.7% | ||
| Q1 25 | 1.3% | 19.2% | ||
| Q4 24 | 7.0% | -3.4% | ||
| Q3 24 | 2.0% | -8.1% | ||
| Q2 24 | 23.4% | 7.7% |
资本支出强度
CCRN
RCMT
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | 0.7% | ||
| Q2 25 | 0.7% | 0.6% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 0.8% | 1.3% | ||
| Q3 24 | 0.4% | 0.9% | ||
| Q2 24 | 0.8% | 0.6% |
现金转化率
CCRN
RCMT
| Q1 26 | — | 3.11× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -0.56× | ||
| Q2 25 | — | -2.08× | ||
| Q1 25 | — | 3.98× | ||
| Q4 24 | — | -0.57× | ||
| Q3 24 | 2.92× | -1.58× | ||
| Q2 24 | — | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RCMT
暂无分部数据